New peptides and New combinations of peptides for use in Immunotherapy against Chronic Lymphocytic Leukemia (CLL) and other types of cancer

摘要

The present Invention relates to Peptides, Proteins, Nucleic acids and Cells for use in immunotherapeutic methods.In particular, The Invention relates to Cancer Immunotherapy.The present Invention also relates to Peptide epitopes for T Lymphocyte Associated Tumors, alone or in combination with other tumor Associated Peptides, e.g.Can serve as active pharmaceutical ingredients in vaccine compositions intended to stimulate antitumor immune responses.To stimulate or ex vivo T lymphocytes which are then transferred to the patients.The peptides bound to Molecules of the major histocompatibility complex (MHC), or peptides as such can also be targets of Antibodies, T Lymphocyte receptor solubleAnd other binding molecules.